bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: N O S A J J M A M F J
2016: D N

 
  Other news for:
Bites and Stings
Hematologic Diseases
Infection
Viruses
 Resources from HONselect
FDA Approves Test to Screen Donated Blood for Zika
Though the virus is mainly spread by mosquitoes, it can be transmitted through blood transfusions

By Mary Elizabeth Dallas

FRIDAY, Oct. 6, 2017 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new test -- called the cobas Zika test -- to screen donated blood for the Zika virus.

"Today's action represents the first approval of a Zika virus detection test for use with screening the nation's blood supply," Dr. Peter Marks said Thursday in an agency news release. Marks is director of the FDA's Center for Biologics Evaluation and Research.

"Screening blood donations for the Zika virus is critical to preventing infected donations from entering the U.S. blood supply. Today's approval is the result of a commitment by the manufacturer to work rapidly and collaboratively with the FDA and the blood collection industry to respond to a public health crisis, and ensure the safety of blood in the U.S. and its territories."

Zika is spread mainly through mosquitoes carrying the virus. It can also be transmitted through sexual contact or blood transfusions.

In August of last year, the FDA advised all states to screen all donated blood and blood products with an experimental screening test accessible under an investigational new drug (IND) application.

An IND allows the FDA to authorize use of an experimental drug in emergency situations. The FDA recommended that an experimental Zika screening test be used until an approved test became available.

Several blood collection centers opted to use the cobas Zika test, which is made by Roche Molecular Systems.

Results from these screenings along with studies conducted by Roche showed the test is an effective way to screen donated blood for the virus. Five different labs found the test accurately identified 99 percent of all infected blood samples.

Zika can cause devastating birth defects in babies whose mothers are infected with the virus while pregnant. The most common of these is microcephaly, a condition in which the baby's head and brain is small and underdeveloped. Thousands of babies in Brazil were born with catastrophic neurological defects linked to the virus when the Zika outbreak there was at its height in 2015 and 2016.

More information

The U.S. Centers for Disease Control and Prevention provides more information on Zika virus.

SOURCE: U.S. Food and Drug Administration, news release, Oct. 5, 2017

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=727276

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Blood
Mass Screening
Bites and Stings
Blood Transfusion
Infection
Blood Donors
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact